\-\ Texto\\:\\ \ \(0\)\
\-\ the\\ patient\\ could\\ recall\\ 2\\ out\\ of\\ 3\\ objects\\ after\\ 5\\ minutes\\ on\\ mini\\ mental\\ status\\ exam\\.\\ \\ she\\ also\\ had\\ a\\ right\\ hemianopsia\\ on\\ physical\\ examination\\.\ \(0\)\
\-\ surgical\\ resection\\ and\\ follow\\-up\\ imaging\ \(0\)\
\-\ 5cm\\ x\\ 4cm\\ x\\ 4\\.4cm\\ cystic\\ intra\\-axial\\ mass\\ with\\ internal\\ septations\\ within\\ the\\ left\\ occipital\\ lobe\\.\\ \\ the\\ mass\\ affects\\ the\\ cortex\\ and\\ causes\\ mass\\ effect\\.\\ \\ \\ the\\ septations\\ show\\ post\\-gadolinium\\ enhancement\\.\\ \\ there\\ is\\ a\\ nodule\\ at\\ the\\ base\\ of\\ the\\ lesion\\ and\\ a\\ curvilinear\\ area\\ at\\ the\\ anterior\\ and\\ superior\\ aspects\\ of\\ the\\ lesion\\ which\\ are\\ hyperintense\\ on\\ pre\\-gadolinium\\ t1\\ images\\ \\-\\ that\\ may\\ represent\\ blood\\ products\\.\\ \\ there\\ is\\ an\\ area\\ of\\ increased\\ flair\\ signal\\ surrounding\\ the\\ lesion\\ that\\ is\\ consistent\\ with\\ intraaxial\\ vasogenic\\ edema\\.\\ \\ there\\ is\\ a\\ 4mm\\ left\\-to\\-right\\ midline\\ shift\\.\\ \\ this\\ lesion\\ also\\ demonstrates\\ increased\\ perfusion\\.\ \(0\)\
\-\ meningeal\\ hemangiopericytoma\ \(0\)\
\-\ \\â\\€\\¢\\ glioblastoma\\ multiforme\ \(0\)\
\-\ \\â\\€\\¢\\ meningioma\ \(7\)\
\-\ \\â\\€\\¢\\ oligodendroglioma\ \(1\)\
\-\ \\â\\€\\¢\\ hemangiopericytoma\ \(1\)\
\-\ \\â\\€\\¢\\ dural\\ metastatsis\\ \\(e\\.g\\.\\ breast\\ ca\\,\\ lymphoma\\)\ \(0\)\
\-\ \\â\\€\\¢\\ sarcoid\ \(3\)\
\-\ \\â\\€\\¢\\ pnet\ \(0\)\
\-\ 35\\ yo\\ woman\\ without\\ significant\\ past\\ medical\\ history\\ who\\ presents\\ with\\ a\\ 2\\ week\\ h\\/o\\ headache\\ and\\ blurry\\ vision\\.\\ \\ episodes\\ of\\ nausea\\/vomiting\\ 3\\ days\\ before\\ presentation\\.\ \(0\)\
\-\ meningeal\\ hemangiopericytomas\\ are\\ rare\\ malignant\\ primary\\ cns\\ neoplasms\\ that\\ arise\\ from\\ the\\ pericytes\\ that\\ surround\\ the\\ endothelial\\ lining\\ of\\ capillaries\\ and\\ venules\\.\\ \\ they\\ make\\ up\\ 2\\.5\\%\\ of\\ meningeal\\ tumors\\ and\\ 1\\%\\ of\\ intracranial\\ tumors\\.\\ the\\ average\\ age\\ at\\ diagnosis\\ is\\ 40\\ years\\ old\\ and\\ these\\ tumors\\ are\\ more\\ common\\ in\\ men\\ than\\ women\\.\\ \\ seventy\\ percent\\ of\\ hemangiopericytomas\\ are\\ supratentorial\\ while\\ 15\\%\\ are\\ found\\ in\\ the\\ posterior\\ fossa\\ and\\ 15\\%\\ percent\\ are\\ spinal\\.\\ \\ patients\\ with\\ supratentorial\\ hemangiopericytomas\\ often\\ present\\ with\\ headache\\ or\\ a\\ focal\\ neurological\\ deficit\\ with\\ only\\ 16\\%\\ presenting\\ with\\ seizures\\.\\ \\ \ \(0\)\
\-\ ct\\ reveals\\ a\\ hyperdense\\ lesion\\ with\\ focal\\ areas\\ of\\ hypodensity\\ and\\ heterogeneous\\ enhancement\\.\\ \\ bone\\ erosion\\ can\\ also\\ be\\ detected\\ on\\ ct\\.\\ \\ mri\\ often\\ shows\\ t1\\ and\\ t2\\ isointensity\\ with\\ flow\\ voids\\.\\ \\ there\\ is\\ also\\ heterogeneous\\ enhancement\\.\\ \\ fifty\\ percent\\ will\\ have\\ a\\ dural\\ tail\\ sign\\.\\ \\ there\\ may\\ be\\ a\\ corkscrew\\ vascular\\ configuration\\.\\ \\ \ \(0\)\
\-\ meningeal\\ hemangiopericytomas\\ are\\ aggressive\\ tumors\\.\\ \\ after\\ gross\\ resection\\,\\ these\\ tumors\\ often\\ recur\\ locally\\,\\ along\\ the\\ neuraxis\\ or\\ outside\\ the\\ cns\\ \\(eg\\ bone\\,\\ lung\\,\\ liver\\)\\ \\ radiation\\ therapy\\ appears\\ to\\ increase\\ disease\\-free\\ survival\\ and\\ overall\\ survival\\.\\ \\ \ \(0\)\
\-\ references\\:\ \(0\)\
\-\ 1\\.\\ \\ chheda\\,\\ mg\\.\\ \\ kesari\\,\\ s\\.\\ \\ wen\\,\\ py\\.\\ \\ uptodate\\ version\\ 15\\.2\\.\\ \\ april\\ 11\\,\\ 2007\\.\ \(0\)\
\-\ 2\\.\\ \\ al\\-mefty\\.\\ o\\.\\ \\ meningiomas\\.\\ \\ raven\\ press\\.\\ \\ new\\ york\\.\\ \\ 1991\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ hemangiopericytomas\\:\\ 0\\.08277482088231454\ \(0\)\
\-\ meningeal\\:\\ 0\\.051157019661784264\ \(0\)\
\-\ tumors\\:\\ 0\\.03767272720270541\ \(0\)\
\-\ percent\\:\\ 0\\.03279320662399173\ \(0\)\
\-\ supratentorial\\:\\ 0\\.025913997924705022\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.02574906211542539\ \(0\)\
\-\ septations\\:\\ 0\\.024563377866245954\ \(0\)\
\-\ hemangiopericytoma\\:\\ 0\\.023952799799353008\ \(0\)\
\-\ \\%\\:\\ 0\\.02339578677636159\ \(0\)\
\-\ survival\\:\\ 0\\.02150897614727342\ \(0\)\
\-\ metastatsis\\:\\ 0\\.020693705220578635\ \(0\)\
\-\ pericytes\\:\\ 0\\.020693705220578635\ \(0\)\
\-\ chheda\\:\\ 0\\.020693705220578635\ \(0\)\
\-\ wen\\:\\ 0\\.020693705220578635\ \(0\)\
\-\ py\\:\\ 0\\.020693705220578635\ \(0\)\
\-\ al\\-mefty\\:\\ 0\\.020693705220578635\ \(0\)\
\-\ cns\\:\\ 0\\.020529892805052498\ \(0\)\
\-\ lesion\\:\\ 0\\.020429051948362142\ \(0\)\
\-\ dural\\:\\ 0\\.01944924689908259\ \(0\)\
\-\ often\\:\\ 0\\.019200517947321496\ \(0\)\
\-\ are\\:\\ 0\\.01914111997114369\ \(0\)\
\-\ mini\\:\\ 0\\.01906659916292618\ \(0\)\
\-\ pre\\-gadolinium\\:\\ 0\\.01906659916292618\ \(0\)\
\-\ venules\\:\\ 0\\.01906659916292618\ \(0\)\
\-\ seventy\\:\\ 0\\.01906659916292618\ \(0\)\
\-\ disease\\-free\\:\\ 0\\.01906659916292618\ \(0\)\
\-\ kesari\\:\\ 0\\.01906659916292618\ \(0\)\
\-\ 4\\.4cm\\:\\ 0\\.018114803134503258\ \(0\)\
\-\ isointensity\\:\\ 0\\.018114803134503258\ \(0\)\
\-\ 15\\.2\\.\\:\\ 0\\.018114803134503258\ \(0\)\
\-\ version\\:\\ 0\\.017439493105273728\ \(0\)\
\-\ neuraxis\\:\\ 0\\.016915681951953986\ \(0\)\
\-\ o\\.\\:\\ 0\\.016915681951953986\ \(0\)\
\-\ raven\\:\\ 0\\.016915681951953986\ \(0\)\
\-\ press\\:\\ 0\\.016915681951953986\ \(0\)\
\-\ enhancement\\:\\ 0\\.01613020257833124\ \(0\)\
\-\ fifty\\:\\ 0\\.016125841020918276\ \(0\)\
\-\ 15\\:\\ 0\\.01600162747655577\ \(0\)\
\-\ also\\:\\ 0\\.015818024353710342\ \(0\)\
\-\ left\\-to\\-right\\:\\ 0\\.015812387047621272\ \(0\)\
\-\ corkscrew\\:\\ 0\\.015812387047621272\ \(0\)\
\-\ nausea\\/vomiting\\:\\ 0\\.015535901048427884\ \(0\)\
\-\ capillaries\\:\\ 0\\.015288575894301533\ \(0\)\
\-\ surround\\:\\ 0\\.015064843077859455\ \(0\)\
\-\ there\\:\\ 0\\.014926238925645405\ \(0\)\
\-\ recall\\:\\ 0\\.01486059101919835\ \(0\)\
\-\ objects\\:\\ 0\\.01486059101919835\ \(0\)\
\-\ endothelial\\:\\ 0\\.01486059101919835\ \(0\)\
\-\ uptodate\\:\\ 0\\.01486059101919835\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.01475208993800472\ \(0\)\
\-\ blurry\\:\\ 0\\.014672697339213524\ \(0\)\
\-\ 5cm\\:\\ 0\\.01449873496326582\ \(0\)\
\-\ intra\\-axial\\:\\ 0\\.014336779865878611\ \(0\)\
\-\ april\\:\\ 0\\.014336779865878611\ \(0\)\
\-\ 1991\\:\\ 0\\.013908794990775433\ \(0\)\
\-\ that\\:\\ 0\\.013858973977078153\ \(0\)\
\-\ locally\\:\\ 0\\.013781876630986052\ \(0\)\
\-\ headache\\:\\ 0\\.013779274354769005\ \(0\)\
\-\ recur\\:\\ 0\\.013546938934842899\ \(0\)\
\-\ hemianopsia\\:\\ 0\\.013437737020207001\ \(0\)\
\-\ 4mm\\:\\ 0\\.013437737020207001\ \(0\)\
\-\ meningiomas\\:\\ 0\\.013437737020207001\ \(0\)\
\-\ intraaxial\\:\\ 0\\.013333390159712086\ \(0\)\
\-\ x\\:\\ 0\\.01323505321759379\ \(0\)\
\-\ lining\\:\\ 0\\.013233484961545897\ \(0\)\
\-\ york\\:\\ 0\\.013137658683329338\ \(0\)\
\-\ 4cm\\:\\ 0\\.012956998962352511\ \(0\)\
\-\ t1\\:\\ 0\\.012715941484620862\ \(0\)\
\-\ area\\:\\ 0\\.012684677202508297\ \(0\)\
\-\ resection\\:\\ 0\\.012511341105728727\ \(0\)\
\-\ post\\-gadolinium\\:\\ 0\\.01248594099178408\ \(0\)\
\-\ hypodensity\\:\\ 0\\.012347817752293625\ \(0\)\
\-\ pnet\\:\\ 0\\.012154770573333598\ \(0\)\
\-\ eg\\:\\ 0\\.012034363778996623\ \(0\)\
\-\ products\\:\\ 0\\.011919832877190445\ \(0\)\
\-\ oligodendroglioma\\:\\ 0\\.011757877779803236\ \(0\)\
\-\ s\\.\\:\\ 0\\.011757877779803236\ \(0\)\
\-\ average\\:\\ 0\\.011706284102059632\ \(0\)\
\-\ multiforme\\:\\ 0\\.011655800052245164\ \(0\)\
\-\ curvilinear\\:\\ 0\\.011557976821257915\ \(0\)\
\-\ aspects\\:\\ 0\\.011557976821257915\ \(0\)\
\-\ voids\\:\\ 0\\.011464067585075522\ \(0\)\
\-\ focal\\:\\ 0\\.011457716451354\ \(0\)\
\-\ affects\\:\\ 0\\.011418485223908616\ \(0\)\
\-\ perfusion\\:\\ 0\\.011418485223908616\ \(0\)\
\-\ men\\:\\ 0\\.011329892904700056\ \(0\)\
\-\ 2007\\:\\ 0\\.011329892904700056\ \(0\)\
\-\ configuration\\:\\ 0\\.011202974544910677\ \(0\)\
\-\ glioblastoma\\:\\ 0\\.011043766572284477\ \(0\)\
\-\ tail\\:\\ 0\\.011043766572284477\ \(0\)\
\-\ mg\\:\\ 0\\.01100559633549626\ \(0\)\
\-\ vasogenic\\:\\ 0\\.010858834934131626\ \(0\)\
\-\ 2\\.5\\:\\ 0\\.010858834934131626\ \(0\)\
\-\ make\\:\\ 0\\.010720711694641172\ \(0\)\
\-\ e\\.g\\:\\ 0\\.010622204185019031\ \(0\)\
\-\ detected\\:\\ 0\\.010590266034653352\ \(0\)\
\-\ h\\/o\\:\\ 0\\.010466689195485697\ \(0\)\
\-\ these\\:\\ 0\\.01044058540825277\ \(0\)\
\-\ minutes\\:\\ 0\\.010378096876277134\ \(0\)\
\-\ deficit\\:\\ 0\\.01034929384202405\ \(0\)\
\-\ sarcoid\\:\\ 0\\.010292726819537992\ \(0\)\
\-\ neoplasms\\:\\ 0\\.010210352829370693\ \(0\)\
\-\ erosion\\:\\ 0\\.010130771722150782\ \(0\)\
\-\ hyperdense\\:\\ 0\\.01002869399459271\ \(0\)\
\-\ overall\\:\\ 0\\.009979272846240991\ \(0\)\
\-\ bone\\:\\ 0\\.0099691769082623\ \(0\)\
\-\ arise\\:\\ 0\\.00993087076360546\ \(0\)\
\-\ episodes\\:\\ 0\\.009907038905708706\ \(0\)\
\-\ increased\\:\\ 0\\.009814482543660356\ \(0\)\
\-\ aggressive\\:\\ 0\\.009814059708302495\ \(0\)\
\-\ women\\:\\ 0\\.009746665093555004\ \(0\)\
\-\ gross\\:\\ 0\\.009555366891087437\ \(0\)\
\-\ shift\\:\\ 0\\.009514893167062775\ \(0\)\
\-\ 3\\:\\ 0\\.009394251299091735\ \(0\)\
\-\ mental\\:\\ 0\\.009359635414704689\ \(0\)\
\-\ occipital\\:\\ 0\\.009359635414704689\ \(0\)\
\-\ ca\\:\\ 0\\.009340930791115072\ \(0\)\
\-\ vision\\:\\ 0\\.009267568012936421\ \(0\)\
\-\ 35\\:\\ 0\\.009231728876479172\ \(0\)\
\-\ flair\\:\\ 0\\.00919642869487227\ \(0\)\
\-\ 11\\:\\ 0\\.00917897569372786\ \(0\)\
\-\ 16\\:\\ 0\\.009076897966169789\ \(0\)\
\-\ represent\\:\\ 0\\.0088096793214543\ \(0\)\
\-\ may\\:\\ 0\\.00879966370374706\ \(0\)\
\-\ neurological\\:\\ 0\\.008679635238379679\ \(0\)\
\-\ 2\\:\\ 0\\.008638988246528386\ \(0\)\
\-\ seizures\\:\\ 0\\.008624072458835301\ \(0\)\
\-\ cortex\\:\\ 0\\.008583246771718237\ \(0\)\
\-\ before\\:\\ 0\\.00849066054624571\ \(0\)\
\-\ intracranial\\:\\ 0\\.008477727081900711\ \(0\)\
\-\ 40\\:\\ 0\\.008439348823681159\ \(0\)\
\-\ outside\\:\\ 0\\.008414107528431717\ \(0\)\
\-\ increase\\:\\ 0\\.008414107528431717\ \(0\)\
\-\ a\\:\\ 0\\.00837886905250566\ \(0\)\
\-\ mass\\:\\ 0\\.008369443710898343\ \(0\)\
\-\ references\\:\\ 0\\.008339972382773739\ \(0\)\
\-\ hyperintense\\:\\ 0\\.008327840997425283\ \(0\)\
\-\ after\\:\\ 0\\.008300475129620668\ \(0\)\
\-\ nodule\\:\\ 0\\.008268107040474192\ \(0\)\
\-\ fossa\\:\\ 0\\.008175585987561336\ \(0\)\
\-\ presenting\\:\\ 0\\.008175585987561336\ \(0\)\
\-\ at\\:\\ 0\\.008153261639659388\ \(0\)\
\-\ is\\:\\ 0\\.007919588427953882\ \(0\)\
\-\ base\\:\\ 0\\.007857883293031378\ \(0\)\
\-\ reveals\\:\\ 0\\.007847999413838083\ \(0\)\
\-\ causes\\:\\ 0\\.007808874877487821\ \(0\)\
\-\ rare\\:\\ 0\\.0077895544569795685\ \(0\)\
\-\ midline\\:\\ 0\\.0077608687496209415\ \(0\)\
\-\ meningioma\\:\\ 0\\.007713824733462617\ \(0\)\
\-\ appears\\:\\ 0\\.007466499579336264\ \(0\)\
\-\ could\\:\\ 0\\.007400370760165616\ \(0\)\
\-\ breast\\:\\ 0\\.007400370760165616\ \(0\)\
\-\ malignant\\:\\ 0\\.007250400648777702\ \(0\)\
\-\ they\\:\\ 0\\.007227573066871611\ \(0\)\
\-\ spinal\\:\\ 0\\.007182573263801845\ \(0\)\
\-\ status\\:\\ 0\\.007160392772726887\ \(0\)\
\-\ effect\\:\\ 0\\.00710224942035034\ \(0\)\
\-\ new\\:\\ 0\\.006990112621597555\ \(0\)\
\-\ sign\\:\\ 0\\.006949404933718476\ \(0\)\
\-\ liver\\:\\ 0\\.006916012936227051\ \(0\)\
\-\ presentation\\:\\ 0\\.006909391160777188\ \(0\)\
\-\ week\\:\\ 0\\.0068122427660287045\ \(0\)\
\-\ on\\:\\ 0\\.006797098707656601\ \(0\)\
\-\ areas\\:\\ 0\\.006749641247056495\ \(0\)\
\-\ internal\\:\\ 0\\.006725060730936083\ \(0\)\
\-\ out\\:\\ 0\\.006629234452719522\ \(0\)\
\-\ flow\\:\\ 0\\.006629234452719522\ \(0\)\
\-\ along\\:\\ 0\\.006629234452719522\ \(0\)\
\-\ surrounding\\:\\ 0\\.0065942846581332525\ \(0\)\
\-\ radiation\\:\\ 0\\.0065827494121181605\ \(0\)\
\-\ vascular\\:\\ 0\\.006577002976346706\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.006525908430614418\ \(0\)\
\-\ superior\\:\\ 0\\.006405501636277445\ \(0\)\
\-\ 2\\.\\:\\ 0\\.0063789768586860526\ \(0\)\
\-\ past\\:\\ 0\\.006373707680625432\ \(0\)\
\-\ found\\:\\ 0\\.0063216563719533155\ \(0\)\
\-\ while\\:\\ 0\\.006311383192141581\ \(0\)\
\-\ will\\:\\ 0\\.00627577703844869\ \(0\)\
\-\ 1\\.\\:\\ 0\\.0062657022683042275\ \(0\)\
\-\ examination\\:\\ 0\\.006235734825057665\ \(0\)\
\-\ be\\:\\ 0\\.0061866512833048315\ \(0\)\
\-\ medical\\:\\ 0\\.006172088732549306\ \(0\)\
\-\ show\\:\\ 0\\.006157643038712737\ \(0\)\
\-\ days\\:\\ 0\\.006148061728103234\ \(0\)\
\-\ age\\:\\ 0\\.006105423299399781\ \(0\)\
\-\ yo\\:\\ 0\\.006036036439677845\ \(0\)\
\-\ only\\:\\ 0\\.006031482766396563\ \(0\)\
\-\ primary\\:\\ 0\\.005942216579567362\ \(0\)\
\-\ years\\:\\ 0\\.005890242105677189\ \(0\)\
\-\ 5\\:\\ 0\\.005868921179446393\ \(0\)\
\-\ lung\\:\\ 0\\.005810232676616775\ \(0\)\
\-\ cystic\\:\\ 0\\.005785522786975959\ \(0\)\
\-\ lymphoma\\:\\ 0\\.005732860644106774\ \(0\)\
\-\ \\,\\:\\ 0\\.0057192267362807196\ \(0\)\
\-\ t2\\:\\ 0\\.005677438424296601\ \(0\)\
\-\ edema\\:\\ 0\\.005673529317913828\ \(0\)\
\-\ she\\:\\ 0\\.00563095338369524\ \(0\)\
\-\ ct\\:\\ 0\\.005611754241277197\ \(0\)\
\-\ shows\\:\\ 0\\.005514961736452767\ \(0\)\
\-\ blood\\:\\ 0\\.0054751433626978865\ \(0\)\
\-\ lobe\\:\\ 0\\.005397477342543507\ \(0\)\
\-\ significant\\:\\ 0\\.0053940073968409\ \(0\)\
\-\ up\\:\\ 0\\.0053940073968409\ \(0\)\
\-\ therapy\\:\\ 0\\.005363006563945101\ \(0\)\
\-\ signal\\:\\ 0\\.005288906878574598\ \(0\)\
\-\ than\\:\\ 0\\.005255983227507685\ \(0\)\
\-\ common\\:\\ 0\\.00524945354919342\ \(0\)\
\-\ who\\:\\ 0\\.005229972791412446\ \(0\)\
\-\ the\\:\\ 0\\.005192461397319279\ \(0\)\
\-\ patients\\:\\ 0\\.005191489669873301\ \(0\)\
\-\ anterior\\:\\ 0\\.005166180337471214\ \(0\)\
\-\ and\\:\\ 0\\.00507067621780897\ \(0\)\
\-\ more\\:\\ 0\\.005016845796507433\ \(0\)\
\-\ physical\\:\\ 0\\.004921373872256428\ \(0\)\
\-\ consistent\\:\\ 0\\.004918540537162449\ \(0\)\
\-\ 1\\:\\ 0\\.004773066591454711\ \(0\)\
\-\ without\\:\\ 0\\.0047230356017797185\ \(0\)\
\-\ or\\:\\ 0\\.004701984736918814\ \(0\)\
\-\ imaging\\:\\ 0\\.004699703813276062\ \(0\)\
\-\ woman\\:\\ 0\\.004633574994105414\ \(0\)\
\-\ posterior\\:\\ 0\\.004623564668315607\ \(0\)\
\-\ mri\\:\\ 0\\.0046086287674052115\ \(0\)\
\-\ diagnosis\\:\\ 0\\.004606148663803803\ \(0\)\
\-\ can\\:\\ 0\\.004549817728800633\ \(0\)\
\-\ present\\:\\ 0\\.004530536981060283\ \(0\)\
\-\ exam\\:\\ 0\\.004406652441196099\ \(0\)\
\-\ demonstrates\\:\\ 0\\.004381739909984005\ \(0\)\
\-\ have\\:\\ 0\\.004343751357664535\ \(0\)\
\-\ had\\:\\ 0\\.00432828596065894\ \(0\)\
\-\ \\-\\:\\ 0\\.004299832062695689\ \(0\)\
\-\ surgical\\:\\ 0\\.004216483028759281\ \(0\)\
\-\ presents\\:\\ 0\\.004097756562225178\ \(0\)\
\-\ images\\:\\ 0\\.0038480373050454324\ \(0\)\
\-\ within\\:\\ 0\\.0038265995502020696\ \(0\)\
\-\ which\\:\\ 0\\.0037444708620717106\ \(0\)\
\-\ \\(\\:\\ 0\\.003391369606778688\ \(0\)\
\-\ \\)\\:\\ 0\\.00334994221649439\ \(0\)\
\-\ from\\:\\ 0\\.002972853786746977\ \(0\)\
\-\ an\\:\\ 0\\.0027738611837669716\ \(0\)\
\-\ history\\:\\ 0\\.0027704566612842332\ \(0\)\
\-\ of\\:\\ 0\\.0027348310046476157\ \(0\)\
\-\ \\.\\:\\ 0\\.002666631819518969\ \(0\)\
\-\ \\:\\:\\ 0\\.002653227267583721\ \(0\)\
\-\ with\\:\\ 0\\.0024719192131666843\ \(0\)\
\-\ this\\:\\ 0\\.002256190641582472\ \(0\)\
\-\ left\\:\\ 0\\.0022443785663683446\ \(0\)\
\-\ right\\:\\ 0\\.0021165063594141237\ \(0\)\
\-\ old\\:\\ 0\\.0020538370818362784\ \(0\)\
\-\ patient\\:\\ 0\\.002010779180554901\ \(0\)\
\-\ in\\:\\ 0\\.001978390751832183\ \(0\)\
\-\ to\\:\\ 0\\.0010025072968145217\ \(0\)\
